Retrospective Chart Review to Evaluate the Effectiveness of the Risk Minimization Measures for the Use of Flupirtine 100 mg Immediate-Release Capsules in daily Practice (Flupirtine-3300) First published 30/09/2015 Last updated 01/04/2024 EU PAS number:EUPAS11134 Study Finalised